Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2016 Mar 25;54(4):1152–1156. doi: 10.1128/JCM.03337-15

Evaluation of Liquid-Based Swab Transport Systems against the New Approved CLSI M40-A2 Standard

Nina Gizzie 1, Emmanuel Adukwu 1,
Editor: E Munson
PMCID: PMC4809939  PMID: 26842703

Abstract

Following revised information pertaining to newer swab types and testing protocols in the new CLSI M40-A2 standard, we evaluated three liquid swab transport systems for the recovery of aerobic, anaerobic, and fastidious organisms at room temperature and at 4°C. All tested liquid swab transport systems were fully compliant with the M40-A2 standard, with acceptable performance at both temperatures after the full specified holding period, using both qualitative (roll-plate) and quantitative (swab elution) methods.

TEXT

Microbiology laboratory diagnosis relies on the recovery of bacterial isolates from clinical specimens. Tissue biopsy and fluid aspiration methods are preferred for collection of clinical samples; however, swab transport systems (STSs) are commonly used due to their low cost and ease of use and the ability to maintain viability for aerobic, anaerobic, and fastidious microorganisms over extended times (1, 2). The second edition of the Clinical and Laboratory Standards Institute (CLSI) M40-A2 standard on the quality control (QC) of microbiological transport systems was published in June 2014 (3), replacing the previous M40-A standard published in 2003 (4). The new M40-A2 standard provides revised testing protocols for liquid transport systems using swab types such as foam swabs and newer “flocked” fiber swabs (3). Routinely, clinical laboratories utilize the roll-plate method to inoculate swab transport devices onto medium plates. For swab validation, however, the M40-A2 standard describes two methods, i.e., a qualitative method (the roll-plate method) and a quantitative method (the swab elution method). The M40-A2 standard expects manufacturers to perform both methods of testing for flocked fiber and foam swabs used in conjunction with liquid media, to ensure the sensitivity of the devices and reliability in clinical settings. The M40-A2 document recommends that end users test swabs by both methods for validation assessments or choose the method that suits their laboratory environment. These new revisions and other additions, such as testing at two different temperatures, would ensure improved accuracy and facilitate better diagnosis.

(This work was presented in part at the 115th General Meeting of the American Society for Microbiology, New Orleans, LA, 30 May to 2 June 2015 [5].)

The STSs used in this study were manufactured and supplied by Medical Wire and Equipment (Corsham, United Kingdom). The STSs included Sigma Transwab PurFlock (flocked swab), Sigma Transwab PurFlock Minitip (flocked swab), and Sigma Transwab (foam swab) swabs. The swabs were used in conjunction with 1 ml of liquid Amies transport medium (E&O Laboratories Ltd., Burnhouse, United Kingdom). Ten American Type Culture Collection (ATCC) bacterial strains (Table 1) were assessed for viability and recovery in accordance with the M40-A2 approved standard. Microorganisms were cultured on plated media (Table 1) and incubated at 37°C under the atmospheric conditions specified in Table 1. Agar plates were incubated under aerobic, anaerobic, or 5% CO2 conditions for 18 to 24 h (a maximum of 48 h for fastidious bacteria and anaerobes). To determine bacterial viability, the methods described in the M40-A2 standard, i.e., the roll-plate (qualitative) and swab elution (quantitative) methods, were followed accordingly.

TABLE 1.

Growth conditions for M40-A2 test microorganisms

Microorganisma Atmosphere Mediumb Incubation time (h)
Pseudomonas aeruginosa ATCC BAA-427 Aerobic Tryptic soy agar 48
Streptococcus pyogenes ATCC 19615 5% CO2 Columbia blood agar 48
Streptococcus pneumoniae ATCC 6305 5% CO2 Columbia blood agar 48
Haemophilus influenzae ATCC 10211 5% CO2 Chocolate agar 48
Bacteroides fragilis ATCC 25285 Anaerobic Columbia blood agar 48
Peptostreptococcus anaerobius ATCC 27337 Anaerobic Columbia blood agar 48
Fusobacterium nucleatum ATCC 25586 Anaerobic Columbia blood agar 48
Propionibacterium acnes ATCC 6919 Anaerobic Columbia blood agar 48
Prevotella melaninogenica ATCC 25845 Anaerobic Columbia blood agar 48
Neisseria gonorrhoeae ATCC 43069 5% CO2 Chocolate agar 24
a

ATCC, American Type Culture Collection.

b

Agar was supplied by E&O Laboratories Ltd. (Scotland).

For the roll-plate method, inocula were prepared to approximately 1.5 × 108 CFU/ml (0.5 McFarland standard) in 0.85% physiological saline, using an 18- to 24-h culture for each microorganism. Final working dilutions of 1.5 × 106 to 1.5 × 104 CFU/ml were prepared, and the dilutions were dispensed in triplicate into a 96-well plate, in 100-μl aliquots for Sigma Transwab PurFlock swabs, 20-μl aliquots for Sigma Transwab Purflock Minitip swabs, or 50-μl aliquots for Sigma Transwab swabs. The swabs were immersed in the aliquots, and the dilutions were absorbed for 10 s. The swabs were then placed in the liquid transport medium and maintained at room temperature (RT) (approximately 24°C) or 4°C for 48 h (24 h for Neisseria gonorrhoeae). After 0, 24, and 48 h, the swabs were removed, rolled directly onto their respective agar plates, and incubated under the required atmospheric conditions (Table 1) for 24 to 48 h, according to the CLSI M40-A2 standard. Enumerated colonies were counted from each plate, and CFU values were determined. The dilution that yielded an inoculum density closest to 250 colonies at time zero was the only dilution used and counted at 24 and 48 h. For overgrowth studies with Pseudomonas aeruginosa, the suspensions were diluted an additional 1:10, to approximately 1.5 × 103 CFU/ml, before being dispensed in triplicate into a 96-well plate; this was to allow measurable yields after incubation.

For the swab elution method, the inocula were prepared in a manner similar to that for the roll-plate method; however, the initial suspensions were diluted 1:10 and dispensed in triplicate into a 96-well plate, in 100-μl aliquots for Sigma Transwab PurFlock swabs, 20-μl aliquots for Sigma Transwab Purflock Minitip swabs, or 50-μl aliquots for Sigma Transwab swabs. The swabs were then placed in 1 ml of liquid Amies transport medium and maintained at RT (approximately 24°C) or 4°C for 48 h (24 h for N. gonorrhoeae). After 0, 24, and 48 h, the swabs were removed and a 10-fold serial dilution, to approximately 1.5 × 102 CFU/ml, was prepared with the liquid Amies transport medium. From each of the dilutions, 50 μl was dispensed onto the respective agar plates (Table 1) using a spiral plater (Don Whitley Scientific, York, United Kingdom). The agar plates were then incubated under the required atmospheric conditions for 24 to 48 h, and the colonies were enumerated.

The M40-A2 standard indicates that, for bacterial recovery from STSs using the roll-plate method, there should be ≥5 CFU after the specified holding period for specimens held at 4°C or RT, from the same dilution as used in time zero plate counts, in order for the viability assessment to be considered acceptable. In overgrowth studies, any specimen held at 4°C should yield no more than a 1-log-unit increase in CFU between time zero and the end of the specified holding period. In our study, all three Sigma Transwab systems met the acceptability criteria for viability studies, as all tested microorganisms yielded ≥5 CFU after the specified holding periods (Table 2). In addition, all Transwab systems met the criteria for overgrowth at 4°C, with no more than 1-log-unit increases for P. aeruginosa (Table 2).

TABLE 2.

Bacterial recovery and overgrowth for foam and flocked swabs over 48 h at room temperature and 4°C, using the roll-plate (qualitative) method

Bacteria and swab type Temperature Bacterial recovery (CFU)a
Compliantb
0 h 24 h 48 h
Pseudomonas aeruginosa ATCC BAA-427
    Purflock RT 117 NA NA NA
4°C 9 52 90 Yes
    Minitip RT 83 NA NA NA
4°C 32 57 83 Yes
    Foam RT 141 NA NA NA
4°C 20 87 109 Yes
Haemophilus influenzae ATCC 10211
    Purflock RT 179 19 5 Yes
4°C 22 12 Yes
    Minitip RT 175 14 6 Yes
4°C 18 6 Yes
    Foam RT 168 11 7 Yes
4°C 42 11 Yes
Streptococcus pneumoniae ATCC 6305
    Purflock RT 156 46 30 Yes
4°C 89 46 Yes
    Minitip RT 145 76 18 Yes
4°C 89 32 Yes
    Foam RT 225 131 74 Yes
4°C 216 202 Yes
Streptococcus pyogenes ATCC 19615
    Purflock RT 154 32 6 Yes
4°C 79 24 Yes
    Minitip RT 195 56 9 Yes
4°C 67 19 Yes
    Foam RT 201 43 12 Yes
4°C 108 23 Yes
Prevotella melaninogenica ATCC 25845
    Purflock RT 112 105 13 Yes
4°C 27 21 Yes
    Minitip RT 59 25 12 Yes
4°C 41 21 Yes
    Foam RT 73 95 38 Yes
4°C 92 80 Yes
Bacteroides fragilis ATCC 25285
    Purflock RT 124 85 67 Yes
4°C 99 82 Yes
    Minitip RT 123 89 54 Yes
4°C 76 70 Yes
    Foam RT 187 108 80 Yes
4°C 105 74 Yes
Peptostreptococcus anaerobius ATCC 27337
    Purflock RT 289 134 45 Yes
4°C 198 61 Yes
    Minitip RT 276 203 104 Yes
4°C 207 125 Yes
    Foam RT 301 176 105 Yes
4°C 165 135 Yes
Propionibacterium acnes ATCC 6919
    Purflock RT 189 54 9 Yes
4°C 52 27 Yes
    Minitip RT 165 43 11 Yes
4°C 54 19 Yes
    Foam RT 187 78 31 Yes
4°C 69 52 Yes
Fusobacterium nucleatum ATCC 25586
    Purflock RT 209 143 86 Yes
4°C 187 104 Yes
    Minitip RT 215 168 78 Yes
4°C 186 124 Yes
    Foam RT 297 215 108 Yes
4°C 246 178 Yes
Neisseria gonorrhoeae ATCC 43069
    Purflock RT 247 8 NA Yes
4°C 13 NA Yes
    Minitip RT 173 14 NA Yes
4°C 17 NA Yes
    Foam RT 273 31 NA Yes
4°C 65 NA Yes
a

NA, not applicable.

b

The M40-A2 compliance criteria were yields of ≥5 CFU (or 1-log-unit increase for P. aeruginosa at 4°C only) after the specified holding period, using the same dilution as for the time zero plates.

For the swab elution method, the M40-A2 standard indicates that, for compliance regarding viability, any specimen held at 4°C or RT should yield no more than a 3-log-unit decrease in CFU between time zero and the end of the specified holding period and, for assessment of overgrowth, any specimen held at 4°C should yield no more than a 1-log-unit increase in CFU between time zero and the end of the specified holding period. Table 3 demonstrates that all three Sigma Transwab systems tested in this study met the viability criteria of the M40-A2 standard, with no more than 3-log-unit decreases in CFU for all microorganisms after the specified holding periods; this included N. gonorrhoeae, which was incubated for only 24 h. Results also showed that the M40-A2 criteria for overgrowth at 4°C were met, with no more than 1-log-unit increases being observed for P. aeruginosa (Table 3).

TABLE 3.

Bacterial recovery and overgrowth for foam and flocked swabs over 48 h at room temperature and 4°C, using the swab elution (quantitative) method

Bacteria and swab type Temperature Bacterial recovery (CFU)a
Log-unit changeb
0 h 24 h 48 h
Pseudomonas aeruginosa ATCC BAA-427
    Purflock RT 4.53 × 107 NA NA NA
4°C 2.37 ×108 1.34 ×108 0.47
    Minitip RT 3.67 ×107 NA NA NA
4°C 8.07 ×107 1.37 ×108 0.57
    Foam RT 3.27 ×107 NA NA NA
4°C 8.73 × 107 3.30 × 108 1.00
Haemophilus influenzae ATCC 10211
    Purflock RT 1.26 ×107 2.04 ×106 4.27 ×105 1.47
4°C 1.23 ×106 6.80 ×105 1.27
    Minitip RT 2.56 ×107 6.00 ×105 5.13 ×105 1.70
4°C 8.67 ×105 5.9 ×105 1.64
    Foam RT 3.27 ×107 1.10 × 106 2.17 × 105 2.18
4°C 1.16 × 106 1.19 × 105 2.44
Streptococcus pneumoniae ATCC 6305
    Purflock RT 3.47 ×106 9.47 ×105 5.27 ×105 0.82
4°C 1.53 ×106 1.05 ×106 0.52
    Minitip RT 3.20 ×106 1.33 ×106 7.07 ×105 0.66
4°C 1.60 ×106 8.40 ×105 0.58
    Foam RT 6.27 ×106 6.40 × 106 1.37 ×106 0.66
4°C 1.73 × 106 6.10 ×106 0.01
Streptococcus pyogenes ATCC 19615
    Purflock RT 3.73 ×106 5.00 ×105 6.40 ×104 1.77
4°C 8.40 ×105 3.00 ×104 2.09
    Minitip RT 3.57 ×106 1.60 ×106 2.37 ×106 0.18
4°C 3.53 ×106 2.53 ×106 0.15
    Foam RT 8.30 ×106 4.53 × 106 2.67 ×106 0.49
4°C 6.70 × 106 7.37 ×106 0.05
Prevotella melaninogenica ATCC 25845
    Purflock RT 1.04 ×107 4.30 ×106 4.57 ×106 0.36
4°C 5.87 ×106 2.80 ×106 0.57
    Minitip RT 6.23 ×106 8.67 ×106 4.53 ×106 0.14
4°C 6.20 ×106 3.80 ×106 0.21
    Foam RT 1.03 ×107 5.20 × 106 9.33 ×106 0.04
4°C 6.07 × 106 6.50 ×106 0.20
Bacteroides fragilis ATCC 25285
    Purflock RT 1.73 ×108 1.06 ×107 7.01 ×106 1.39
4°C 3.46 ×107 5.43 ×106 1.50
    Minitip RT 9.13 ×107 9.23 ×106 3.40 ×106 1.43
4°C 3.77 ×106 5.61 ×106 1.21
    Foam RT 9.83 ×107 1.63 × 107 7.10 ×106 1.14
4°C 4.57 × 107 9.41 ×106 1.02
Peptostreptococcus anaerobius ATCC 27337
    Purflock RT 9.85 ×107 5.05 ×106 4.75 ×105 2.32
4°C 9.04 ×106 7.36 ×105 2.13
    Minitip RT 8.84 ×107 9.85 ×106 1.02 ×106 1.94
4°C 1.85 ×107 8.71 ×106 1.01
    Foam RT 2.56 ×108 7.01 × 106 2.04 ×106 2.10
4°C 9.56 × 107 2.30 ×107 1.05
Propionibacterium acnes ATCC 6919
    Purflock RT 6.29 ×107 9.23 ×106 2.40 ×105 2.42
4°C 3.04 ×107 8.72 ×106 0.86
    Minitip RT 6.76 ×107 1.99 ×107 1.86 ×106 1.56
4°C 8.30 ×106 9.86 ×106 0.84
    Foam RT 7.04 ×107 6.25 × 106 4.31 ×106 1.21
4°C 1.21 × 107 6.96 ×106 1.00
Fusobacterium nucleatum ATCC 25586
    Purflock RT 8.67 ×107 4.43 ×106 1.02 ×105 2.93
4°C 6.21 ×107 3.65 ×106 1.38
    Minitip RT 6.07 ×107 9.06 ×106 3.43 ×105 2.25
4°C 8.91 ×106 5.61 ×106 1.03
    Foam RT 4.35 × 108 4.71 × 107 9.09 ×106 1.68
4°C 9.09 × 107 5.41 ×107 0.91
Neisseria gonorrhoeae ATCC 43069
    Purflock RT 7.5 × 104 8.6 × 101 NA 2.94
4°C 1.4 × 102 NA 2.73
    Minitip RT 4.5 × 104 1.4 × 102 NA 2.51
4°C 7.9 × 103 NA 0.76
    Foam RT 8.13 ×106 4.67 × 105 NA 1.24
4°C 1.20 × 106 NA 0.83
a

NA, not applicable.

b

The M40-A2 compliance criteria were no greater than a 3-log-unit decrease at 4°C or room temperature or a 1-log-unit increase for P. aeruginosa at 4°C only. The log-unit change was calculated as log(48-h value) − log(time zero value).

The M40-A2 standard was revised as a result of numerous study data and incorporated redefined testing protocols to include new swab types and better defined temperatures for QC testing (3). Prior to the recently published M40-A2 standard, swab transport systems, including the swab tip formats used in this study, were evaluated for viability and recovery using only one test method, i.e., the swab elution method or the roll-plate method (2, 6). To our knowledge, our study is the first evaluation of STSs using both methods since the revision and publication of the M40-A2 standard. Other studies that were published recently utilized either a single method of assessment (the roll-plate method) (7) or a different method (a high-throughput homogenizer) (8), not indicated in the M40-A2 document. In our study, all three swab formats tested were compliant with the M40-A2 criteria for viability studies. This is in contrast to the data reported by Avolio and Camporese (7), which suggested that one of the swab formats tested in our study, the Sigma Transwab (foam) format, failed the CLSI acceptance criteria; we addressed this in our letter to the editor (9).

The three Sigma Transwab systems were found to have acceptable performance at both temperatures after the full specified holding period, using both qualitative (roll-plate) and quantitative (swab elution) methods. In addition, we recommend that commercially available liquid medium transport systems used in conjunction with foam or flocked swabs be internally evaluated using both qualitative and quantitative methods, to ensure the sensitivity of the system, the reliability of the results in clinical settings, and compliance with the M40-A2 standard.

REFERENCES

  • 1.Rishmawi N, Ghneim R, Kattan R, Ghneim R, Zoughbi M, Abu-Diab A, Turkuman S, Dauodi R, Shomali I, Issa AE, Siriani I, Marzouka H, Schmid I, Hindiyeh MY. 2007. Survival of fastidious and nonfastidious aerobic bacteria in three bacterial transport swab systems. J Clin Microbiol 45:1278–1283. doi: 10.1128/JCM.02110-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Morosini MI, Loza E, Guitierrez O, Almaraz F, Baquero F, Canton R. 2006. Evaluation of 4 swab transport systems for the recovery of ATCC and clinical strains with characterized resistance mechanisms. Diagn Microbiol Infect Dis 56:19–24. doi: 10.1016/j.diagmicrobio.2006.02.011. [DOI] [PubMed] [Google Scholar]
  • 3.Clinical and Laboratory Standards Institute. 2014. Quality control of microbiological transport systems; approved standard— 2nd ed CLSI document M40-A2. Clinical and Laboratory Standards Institute, Wayne, PA. [Google Scholar]
  • 4.Clinical and Laboratory Standards Institute. 2003. Quality control of microbiological transport systems; approved standard M40-A. CLSI document M40-A. Clinical and Laboratory Standards Institute, Wayne, PA. [Google Scholar]
  • 5.Gizzie NY, Adukwu EC. 2015. Using the new CLSI M40-A2 standard coupled with molecular criteria to assess the performance of Sigma Transwab® PurFlock® (standard and mini-tip) with liquid Amies medium, poster 1084. Abstr 115th Gen Meet Am Soc Microbiol. American Society for Microbiology, Washington, DC. [Google Scholar]
  • 6.Van Horn KG, Audette C, Sebeck D, Tucker K. 2008. Comparison of the Copan ESwab system with two Amies agar swab transport systems for maintenance of microorganism viability. J Clin Microbiol 46:1655–1658. doi: 10.1128/JCM.02047-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Avolio M, Camporese A. 2015. Liquid based microbiological transport systems: conformity assessment of two commercial devices. J Microbiol Methods 115:42–44. doi: 10.1016/j.mimet.2015.05.004. [DOI] [PubMed] [Google Scholar]
  • 8.Warnke P, Redanz S, Zaatreh S, Podbielski A. 2016. Augmented recovery of microorganisms from swabs by homogenization: a novel standardizable high-throughput approach. Diagn Microbiol Infect Dis 84:16–18. doi: 10.1016/j.diagmicrobio.2015.10.004. [DOI] [PubMed] [Google Scholar]
  • 9.Adukwu EC, Gizzie NY. 2015. Letter to the editor. J Microbiol Methods 118:187. doi: 10.1016/j.mimet.2015.09.003. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES